Sebastian Kreuz

2.5k total citations · 1 hit paper
24 papers, 1.9k citations indexed

About

Sebastian Kreuz is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Sebastian Kreuz has authored 24 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Sebastian Kreuz's work include Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and NF-κB Signaling Pathways (5 papers). Sebastian Kreuz is often cited by papers focused on Virus-based gene therapy research (8 papers), RNA Interference and Gene Delivery (5 papers) and NF-κB Signaling Pathways (5 papers). Sebastian Kreuz collaborates with scholars based in Germany, United States and Austria. Sebastian Kreuz's co-authors include Harald Wajant, Peter Scheurich, Daniela Siegmund, Dominik F. Aschauer, Simon Rumpel, Benjamin Strobel, Birgit Stierstorfer, Michael Kracht, Oliver Dittrich‐Breiholz and Martin Leverkus and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Sebastian Kreuz

24 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain

2013 405 citations Dominik F. Aschauer, Sebastian Kreuz et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sebastian Kreuz Germany	17	1.3k	463	360	287	251	24	1.9k
I‐Shing Yu Taiwan	26	1.2k 0.9×	227 0.5×	292 0.8×	240 0.8×	138 0.5×	72	1.9k
Qi Ding China	24	1.4k 1.1×	189 0.4×	467 1.3×	196 0.7×	510 2.0×	96	2.1k
Gustavo Pedraza‐Alva Mexico	24	1.2k 0.9×	504 1.1×	304 0.8×	207 0.7×	235 0.9×	53	2.0k
Ning‐Yi Shao United States	26	2.1k 1.6×	190 0.4×	415 1.2×	374 1.3×	260 1.0×	53	2.8k
Xiaoju Max United States	4	2.3k 1.8×	282 0.6×	275 0.8×	205 0.7×	265 1.1×	8	2.9k
Emilia Turco Italy	27	1.7k 1.3×	231 0.5×	364 1.0×	196 0.7×	426 1.7×	67	2.6k
Jueng Soo You South Korea	23	2.0k 1.6×	208 0.4×	459 1.3×	247 0.9×	269 1.1×	46	2.5k
Benoît Bilanges United Kingdom	20	2.0k 1.5×	323 0.7×	254 0.7×	300 1.0×	378 1.5×	27	2.9k
Teresa L. Johnson‐Pais United States	24	1.5k 1.2×	205 0.4×	182 0.5×	316 1.1×	388 1.5×	66	2.3k
Iva Klevernic United Kingdom	10	2.0k 1.6×	299 0.6×	292 0.8×	178 0.6×	454 1.8×	10	2.7k

Countries citing papers authored by Sebastian Kreuz

Since Specialization

Citations

This map shows the geographic impact of Sebastian Kreuz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Kreuz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Kreuz more than expected).

Fields of papers citing papers by Sebastian Kreuz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Kreuz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Kreuz. The network helps show where Sebastian Kreuz may publish in the future.

Co-authorship network of co-authors of Sebastian Kreuz

This figure shows the co-authorship network connecting the top 25 collaborators of Sebastian Kreuz. A scholar is included among the top collaborators of Sebastian Kreuz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sebastian Kreuz. Sebastian Kreuz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sayers, Ian, Charlotte K. Billington, Marc A. Grundl, et al.. (2024). Interleukin‐1 receptor‐associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll‐like receptors 4 and 7/8 in murine and human lungs. British Journal of Pharmacology. 181(22). 4647–4657. 2 indexed citations

Vieyra-Garcia, Pablo, Benjamin Strobel, Tanja Schönberger, et al.. (2024). Riboswitch-controlled IL-12 gene therapy reduces hepatocellular cancer in mice. Frontiers in Immunology. 15. 1360063–1360063. 11 indexed citations

Kienle, Eike, Martin Oti, María Méndez-Lago, et al.. (2023). An unbiased AAV-STARR-seq screen revealing the enhancer activity map of genomic regions in the mouse brain in vivo. Scientific Reports. 13(1). 6745–6745. 10 indexed citations

Strobel, Benjamin, Holger Klein, Germán Leparc, et al.. (2022). Time and phenotype-dependent transcriptome analysis in AAV-TGFβ1 and Bleomycin-induced lung fibrosis models. Scientific Reports. 12(1). 12190–12190. 13 indexed citations

Blazevic, Dragica, et al.. (2022). MSD-based assays facilitate a rapid and quantitative serostatus profiling for the presence of anti-AAV antibodies. Molecular Therapy — Methods & Clinical Development. 25. 360–369. 9 indexed citations

Sahu, Amrita, Sunita Shinde, Jian Cui, et al.. (2021). The biphasic and age-dependent impact of klotho on hallmarks of aging and skeletal muscle function. eLife. 10. 36 indexed citations

Michelfelder, Stefan, Felix Schiele, Sebastian Kreuz, et al.. (2021). Development of a Bispecific Antibody-Based Platform for Retargeting of Capsid Modified AAV Vectors. International Journal of Molecular Sciences. 22(15). 8355–8355. 11 indexed citations

Strobel, Benjamin, Holger Klein, Dragica Blazevic, et al.. (2020). High-throughput identification of synthetic riboswitches by barcode-free amplicon-sequencing in human cells. Nature Communications. 11(1). 714–714. 33 indexed citations

Strobel, Benjamin, Gudrun Zimmermann, Christine Mayer, et al.. (2019). Standardized, Scalable, and Timely Flexible Adeno-Associated Virus Vector Production Using Frozen High-Density HEK-293 Cell Stocks and CELLdiscs. Human Gene Therapy Methods. 30(1). 23–33. 42 indexed citations

10.

Gilhodes, Jean-Claude, et al.. (2017). Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis. PLoS ONE. 12(1). e0170561–e0170561. 61 indexed citations

11.

Strobel, Benjamin, et al.. (2017). Comparative analysis of lysyl oxidase (like) family members in pulmonary fibrosis. Scientific Reports. 7(1). 149–149. 99 indexed citations

12.

Ackermann, Maximilian, Yong Oock Kim, Willi L. Wagner, et al.. (2017). Effects of nintedanib on the microvascular architecture in a lung fibrosis model. Angiogenesis. 20(3). 359–372. 93 indexed citations

13.

Strobel, Benjamin, Birgit Stierstorfer, Detlef Stiller, et al.. (2015). Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2. American Journal of Respiratory Cell and Molecular Biology. 53(3). 291–302. 28 indexed citations

14.

Strobel, Benjamin, Benedikt Klauser, Jörg S. Hartig, et al.. (2015). Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells. Molecular Therapy. 23(10). 1582–1591. 49 indexed citations

15.

Geiger, Matthias, Gerd Luippold, Gerald Birk, et al.. (2014). Gene Delivery to Adipose Tissue Using Transcriptionally Targeted rAAV8 Vectors. PLoS ONE. 9(12). e116288–e116288. 18 indexed citations

16.

Aschauer, Dominik F., Sebastian Kreuz, & Simon Rumpel. (2013). Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain. PLoS ONE. 8(9). e76310–e76310. 405 indexed citations breakdown →

17.

Baum, Patrick, Katrin Fundel‐Clemens, Sebastian Kreuz, et al.. (2009). Off-Target Analysis of Control siRNA Molecules Reveals Important Differences in the Cytokine Profile and Inflammation Response of Human Fibroblasts. Oligonucleotides. 20(1). 17–26. 17 indexed citations

18.

Kreuz, Sebastian, Corinna Schoelch, Leo Thomas, et al.. (2009). Acetyl‐CoA carboxylases 1 and 2 show distinct expression patterns in rats and humans and alterations in obesity and diabetes. Diabetes/Metabolism Research and Reviews. 25(6). 577–586. 29 indexed citations

19.

Kreuz, Sebastian, Daniela Siegmund, Peter Scheurich, & Harald Wajant. (2001). NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling. Molecular and Cellular Biology. 21(12). 3964–3973. 497 indexed citations

20.

Wajant, Harald, Elvira Haas, Ralph Schwenzer, et al.. (2000). Inhibition of Death Receptor-mediated Gene Induction by a Cycloheximide-sensitive Factor Occurs at the Level of or Upstream of Fas-associated Death Domain Protein (FADD). Journal of Biological Chemistry. 275(32). 24357–24366. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact